SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
372Danish Genmab/CEO Sees HuMax-CD4 On Sale in 2004 COPENHAGEN -(Dow Jones)- Danishnigel bates-4/22/2002
371"Monoclonal TCRs" Message 17351841nigel bates-4/18/2002
370Psoriasis Patients in Genmab's HuMax-CD4 Phase II Trial Experience Long LastIcebrg-4/12/2002
369Genmab and Paradigm Therapeutics Announce Major Alliance on Discovery Targets Fonigel bates-4/11/2002
368>>Enzon and Micromet Announce Strategic Collaboration for Novel Single-ChaIcebrg-4/10/2002
367Enzon and Micromet Announce Strategic Collaboration for Novel Single-Chain Antibnigel bates-4/10/2002
366Amazingly, in view of the importance of this compound to them, still no PR from nigel bates-4/10/2002
365From the Peptech annual report (Dec 2001)... In the year under review, Diversysnigel bates-4/9/2002
364Apropos both Diversys and D2E7... Friday, 01 March 2002 Peptech - Managing Direnigel bates-4/9/2002
363Diversys contd. Management Robert T Connelly is Chief Executive Officer of Divnigel bates-4/9/2002
362(Diversys) Just parking... Cambridge, UK, 25th September, 2001... Diversys Liminigel bates-4/9/2002
361Probably no PR from CAT today, as many UK companies are postponing news releasesnigel bates-4/9/2002
360Answering my own question. It is CAT. From their website. <i>Knoll (a subIcebrg-4/9/2002
359From Abbott's news release this morning: <i>ABBOTT PARK, Ill., April Icebrg-4/9/2002
358biz.yahoo.com New deal Vivenetia and Xoma. Viventia Biotech licenses XOMA'aknahow-4/3/2002
357Celltech and Seattle Genetics Announce Antibody-Drug Conjugate Collaboration SLIcebrg-3/28/2002
356A minute's virtual silence on the thread, in memory of Cesar Milstein, jointnigel bates-3/26/2002
355OGS and BioInvent form Therapeutic Antibodies Alliance OXFORD, UK and LUND, Swenigel bates-3/14/2002
354OGS and BioInvent form Therapeutic Antibodies Alliance OXFORD, UK and LUND, SweIcebrg-3/14/2002
353Monday March 11 Genmab and Bionomics to Co-Develop Human Antibodies for Angiogenigel bates-3/12/2002
352Biosite Announces Collaboration Agreement With Amgen; Amgen to access the Medarenigel bates-3/11/2002
351ProMetic Technology Reaches New Milestones For Monoclonal Antibody (MAb) Purificnigel bates-3/11/2002
350Just parking. This is a bit old, but interesting background stuff - Novel humannigel bates-3/4/2002
349I bought some more. IceIcebrg-3/1/2002
348So did I, had a nice gain for a while but got stopped out at 17.99. A very badltom pope-3/1/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News